Navigation Links
Cepheid Reports Fourth Quarter and Full Year 2011 Results
Date:1/26/2012

in spite of continuing tight capital availability in the US and Europe.  In 2012, we will continue to invest aggressively in Xpert® test menu expansion to enable the benefits of our system to be realized in broader segments of the market. We expect to further extend our technology leadership and strong growth momentum in the quarters and years ahead."

Operational Overview

  • Fourth quarter of 2011 Clinical sales of $68.9 million grew 39% from $49.5 million in the fourth quarter of 2010, and total fourth quarter of 2011 product sales of $76.9 million grew 37% from the same quarter a year ago.  For the year ended December 31, 2011, total Clinical sales of $236.0 million grew 36% from $173.8 million reported for the same period a year ago.  
  • By industry, product sales were, in millions:

  • Three Months Ended December 31,Full Year Ended December 31,20112010Change20112010ChangeClinical Systems

    $
    9.9$
    2.758%$
    58.6$
    42.538%Clinical Reagents

    49.036.833%177.4131.335%Total Clinical 68.949.539%236.0173.836%Non-Clinical

    8.06.719%29.533.1-11%Total Product Sales$
    76.9$
    56.237%$
    265.5$
    206.928%

  • By geography, product sales were, in millions:
  • Three Months Ended December 31,Full Year Ended December 31,20112010Change20112010ChangeNorth AmericaClinical

    $
    46.4$
    38.521%$
    7.9$
    37.322%Other

    7.25.433%25.027.3-8%Total North America53.643.922%192.9164.617%InternationalClinical

    22.511.0105%68.136.587%Other

    0.81.3-38%4.55.8-22%Total International23.312.389%72.642.372%Total Product Sales$
    76.9$
    56.237%$
    265.5$
    206.928%

  • During the fourth quarter of 2011, Cepheid placed a total of 175 GeneXpert systems in its commercial Clinical business.  Additionally, the Company placed a total of 181 GeneXpert systems as part of its High Burden Developing Country (HBDC) program.  For the year ended December 31, 2011, Cepheid placed a to
    '/>"/>

  • SOURCE Cepheid
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. Cepheid Welcomes Senior Vice President of Human Resources
    2. Cepheid Receives FDA Clearance for Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
    3. Cepheid Schedules 2010 Third Quarter Financial Results Announcement and Webcast
    4. Cepheid to Webcast Upcoming Financial Presentations
    5. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
    6. Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast
    7. Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast
    8. Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
    9. Cepheid Reports 2009 First Quarter Results
    10. Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
    11. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... ELLYN, Ill. , July 2, 2015 ... Colton Eakins are gaining invaluable real-world experiences ... of Technology this summer. The students will ... Dr. Jeff Wereszczynski,s research group at IIT. The ... Dr. Tom Carter , Physics; Dr. Kathy ...
    (Date:7/2/2015)... ... 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), a ... the acquisition of Turner Medical, Inc ., thus becoming a global leader ... Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s product offering, ...
    (Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... The next-generation ... several key market segments, including the molecular diagnostics industry. BCC Research reveals in its ... of NGS-based tests, lower test costs, and a growing need for better diagnostics as ...
    (Date:7/1/2015)... Ariz. , July 1, 2015 Isagenix ... it has earned three Gold, three Silver, and three ... Awards gala held in Chicago ... as the premier business awards program in the U.S. ... recognizes our company,s strength in developing leaders, cultivating talent, ...
    Breaking Biology Technology:COD Students Participate in Prestigious Summer Internships 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
    ... Mass. and TORONTO, Sept. 16, 2011 Generex ... today that Dr. Nicola Napolii, from University Campus ... of the clinical data on Generex Oral-lyn™ buccal ... European Association for the Study of Diabetes (EASD) ...
    ... (NASDAQ: AMGN ) will participate in the UBS ... the Grand Hyatt in New York City, beginning at 8:30 ... president of Research and Development at Amgen, will present at ... from the Events Calendar on Amgen,s website, www.amgen.com , ...
    ... for Brain Science announced today the discovery of a new ... neural stem cells, offering a fresh avenue in the search ... published collaborative study, authored by scientists from the University of ... Montreal Neurological Institute and Hospital at McGill University and titled ...
    Cached Biology Technology:Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting 2Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting 3Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting 4New Class of Stem Cell-Like Cells Discovered in Spinal Cord Offers Possibilities for Spinal Cord Repair 2New Class of Stem Cell-Like Cells Discovered in Spinal Cord Offers Possibilities for Spinal Cord Repair 3
    (Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
    (Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
    (Date:6/25/2015)...  TAKE Solutions Ltd., a global business technology solutions ... Patent and Trademark Office (USPTO) for its "Method for ... Clinical Accelerators to reduce the time taken to standardize ... without the accelerators), thus reducing time to market. ... the heart of the patented Clinical Data Standardization Process ...
    Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
    ... may contribute to increased productivity in sustainable agriculture, according ... issue of the journal Science. The study analyzes, ... experiments all over the world, involving corn and cotton ... properties. The research was conducted by scientists at ...
    ... water could provide an early indicator of climate change. ... could forewarn of climate change in 10 to 20 ... Science Foundation (ESF) conference, scientists predicted that the waters ... New Zealand are the places to watch. , Palaeoclimate ...
    ... million people worldwide were estimated to be living with Alzheimer’s ... at the Johns Hopkins Bloomberg School of Public Health. The ... grow to more than 106 million by 2050. By that ... high-level care, equivalent to that of a nursing home. The ...
    Cached Biology News:New study finds genetically engineered crops could play a role in sustainable agriculture 2Salty oceans provide early warning for climate change 2Alzheimer's disease to quadruple worldwide by 2050 2
    ... XIII in both reduced and non-reduced forms. It ... or human Factor XII. Factor XIII is a ... two subunits. Factor XIII-A is the catalytic subunit ... XIII is present in plasma as an Alpha2Beta2 ...
    ... Anti-Lipid Phosphate Phosphatase 2 ... buffered aqueous solution ... saline containing 0.08% sodium ... from the human LPP2 ...
    Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
    ... Anti-MAPKAPK-2, Phospho-Specific(Thr 222 ) ... NaCl, 10 mM sodium HEPES, ... pH 7.5. Recognizes the ~47 ... 2 (MAPKAPK-2) protein phosphorylated at ...
    Biology Products: